Andrew Hollman Meyer insider trades

Open-market stock purchases and sales by Andrew Hollman Meyer, Chief Business Officer at Janux Therapeutics, Inc, from SEC Form 4 filings since Jan 3, 2022.

Recent trades

DateStockTradeValue
Jan 2, 2026JANX Janux Therapeutics, IncSold$25.8K
Dec 1, 2025JANX Janux Therapeutics, IncBought (not open market)—
Dec 1, 2025JANX Janux Therapeutics, IncSold$88.7K
Dec 1, 2025JANX Janux Therapeutics, IncSold$21.2K
Nov 14, 2025JANX Janux Therapeutics, IncSold$100K
Nov 14, 2025JANX Janux Therapeutics, IncBought (not open market)—
Oct 28, 2025JANX Janux Therapeutics, IncSold$501K
Oct 28, 2025JANX Janux Therapeutics, IncBought (not open market)—
Oct 28, 2025JANX Janux Therapeutics, IncBought (not open market)—

Companies traded

  • JANX Janux Therapeutics, Inc: 19 sales, last Jan 2, 2026

Get free alerts when Andrew Hollman Meyer files a new trade →